Impact of pharmaceutical representative visits on GPs' drug preferences.

Impact of pharmaceutical representative visits on GPs' drug preferences.

Item
http://www.wikidata.org/entity/Q43693980
Patented drug extension strategies on healthcare spending: a cost-evaluation analysisInfluence of Medical Representatives on Prescribing Practices in Mekelle, Northern EthiopiaAssociation between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysisAntibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing--an Irish perspective.Changing interactions between physician trainees and the pharmaceutical industry: a national survey.Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature.Urban-rural differences in the uptake of new oral bisphosphonate formulations.Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.
P2860

Impact of pharmaceutical representative visits on GPs' drug preferences.

Item
http://www.wikidata.org/entity/Q43693980
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Impact of pharmaceutical representative visits on GPs' drug preferences.
@en
Impact of pharmaceutical representative visits on GPs' drug preferences.
@nl
type
label
Impact of pharmaceutical representative visits on GPs' drug preferences.
@en
Impact of pharmaceutical representative visits on GPs' drug preferences.
@nl
prefLabel
Impact of pharmaceutical representative visits on GPs' drug preferences.
@en
Impact of pharmaceutical representative visits on GPs' drug preferences.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Impact of pharmaceutical representative visits on GPs' drug preferences.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698